In a world already grappling with disruptions to essential health supplies, a new and intimate challenge is emerging. Karex, the Malaysian company responsible for manufacturing one in every five condoms globally, has issued a sobering warning: the ongoing conflict involving Iran is straining supply chains to a breaking point. According to CEO Goh Miah Kiat, if shipping routes and material flows continue to be disrupted, the company will be forced to raise its prices by a significant 20% to 30%. This isn’t just a story about a corporate bottom line; it’s about the potential cost increase for a fundamental health commodity used by millions worldwide. Karex produces a staggering five billion condoms annually, supplying major brands like Durex and Trojan, as well as critical public health bodies such as the UK’s National Health Service and UN agencies, making this an issue with truly global resonance.
The ripple effects of geopolitical conflict are often felt in unexpected places, and now they have reached the factory floors where condoms are made. Goh explains that the war has driven up costs for nearly every component required in production. The prices for synthetic rubber and nitrile—key materials for non-latex varieties—have climbed, alongside costs for the essential packaging materials and lubricants like silicone oil. Crucially, the conflict’s impact on maritime traffic through the strategic Strait of Hormuz has snarled supply chains for the petrochemical derivatives used in manufacturing. Furthermore, suppliers of aluminium and naphtha, which are vital for packaging, are also reporting major disruptions. These compounding pressures leave companies like Karex little room to absorb the shocks, forcing a difficult decision to pass costs to consumers and health organizations.
This supply chain crisis is colliding with a pre-existing and alarming global shortage of condoms, creating a perfect storm for sexual and reproductive health. The shortfall traces back to the dismantling of the United States Agency for International Development (USAID), which was once the largest bilateral donor for global family planning. USAID provided an estimated 35% of contraceptives within international supply chains, serving 23 countries. Its absence has left a devastating gap, particularly in regions of Africa and the Middle East that relied heavily on its support. Data from the Joint United Nations Programme on HIV/AIDS paints a stark picture: for instance, Nigeria witnessed a 55% decline in male condom distribution in just a few months at the end of 2024. These shortages threaten decades of progress in HIV prevention, family planning, and maternal health.
Amidst this strained landscape, Karex is facing its own logistical nightmares. The company reports that shipments destined for Europe and the United States are now taking nearly two months to arrive, with some vessels completely stuck and unable to reach their ports. Paradoxically, these very delays are contributing to a surge in demand, as prolonged transit times deplete the existing stockpiles held by distributors and health programs. “The situation is definitely very fragile, prices are expensive. We have no choice but to transfer the costs right now to the customers,” Goh stated bluntly to Reuters. While the company asserts it has enough raw materials to maintain production for the coming months and is looking to boost output, the long-term outlook remains uncertain, hinging on the resolution of conflicts far beyond its control.
The production process itself highlights the vulnerability of this essential item. Most condoms are crafted from natural rubber latex, harvested from the sap of rubber trees, while alternatives for those with latex allergies are made from materials like nitrile and polyurethane—the very petrochemical products now caught in shipping snarls. This situation underscores how interconnected and fragile our global manufacturing webs truly are. A conflict in one region can disrupt the supply of aluminium foil for a condom wrapper or the silicone for a personal lubricant, ultimately affecting the cost and availability of a product that represents safety, responsibility, and health for people across the globe.
Ultimately, the potential price hike for condoms is more than an economic headline; it is a public health alert. As costs rise, the burden will fall hardest on the most vulnerable: public health systems like the NHS, international aid organizations fighting HIV/AIDS, and individuals in low-income communities who already face barriers to accessing contraception. The warning from the world’s largest condom manufacturer is a clear signal that geopolitical instability has very human consequences, reaching into the most private aspects of our lives. It calls for a renewed focus on strengthening and diversifying supply chains for essential health commodities, ensuring that regardless of world events, access to basic preventive care remains protected and equitable for all.
